(b)(4).Foreign report source: (b)(6).The reported event was unable to be confirmed as the product was not returned.The device was not returned to the manufacturer.Therefore it could not be analyzed.The review of the device manufacturing quality record indicate that (b)(4) products désignation refobacin bone cement r40x1, reference (b)(4), batch a749dc0513 were manufactured on 10 april 2018.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the complaint event described in the complaint.1 similar complaint has been recorded for refobacin bone cement r 1x40g, reference (b)(4), batch a749dc0513 within one year.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|